{"title": "Hepatitis C", "author": "Juan Carlos Restrepo Guti\u00e9rrez; Ana Isabel Toro Montoya", "url": null, "hostname": null, "description": "Hepatitis C is a disease caused by hepatitis C virus and is the leading cause of cirrhosis and liver transplantation in the Western world. It is estimated that 3% of the world population is infected with this virus. Most infections are asymptomatic or can manifest nonspecific symptoms like fatigue, nausea, myalgia and fever, which can make the initial diagnosis more difficult. In the progression of the disease to the chronic stage, several factors can participate, including viral, host and external factors. The finding of abnormal laboratory tests or signs of cirrhosis should make the clinician consider hepatitis C. For the diagnosis, there are serological and virological assays available; serological assays detect antibodies against the virus, while virological assays can detect the viral RNA. The wide variety of quasispecies and the virus variability have not allowed the synthesis of a vaccine that provides protection.", "sitename": "Medicina y Laboratorio", "date": "2011-09-01", "id": null, "license": "CC BY-NC-ND 4.0", "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Hepatitis C\nResumen\nLa hepatitis C es una enfermedad causada por el virus de la hepatitis C y es la principal causa de cirrosis y trasplante hep\u00e1tico en el mundo occidental. Se estima que el 3% de la poblaci\u00f3n mundial est\u00e1 infectada por este virus. La mayor\u00eda de las infecciones son asintom\u00e1ticas y cuando se manifiestan aparecen s\u00edntomas inespec\u00edficos como fatiga, n\u00e1usea, mialgias y fiebre, que pueden hacer dif\u00edcil el diagn\u00f3stico inicial. En la progresi\u00f3n de la enfermedad a la etapa cr\u00f3nica participan factores relacionados con el virus, el hospedero y tambi\u00e9n algunos factores externos. El hallazgo de unas pruebas de laboratorio anormales o signos de cirrosis debe hacer pensar en una hepatitis C. Para el diagn\u00f3stico se dispone de pruebas serol\u00f3gicas y virol\u00f3gicas; las serol\u00f3gicas detectan anticuerpos contra el virus, en tanto que las virol\u00f3gicas detectan el RNA viral. La gran variedad de cuasiespecies y la variabilidad del virus de la hepatitis C no han permitido hasta ahora la s\u00edntesis de una vacuna que brinde protecci\u00f3n.\nDescargas\nReferencias bibliogr\u00e1ficas\nSenecal DL, Morelli J. Hepatitis C virus infection: a current review. JAAPA 2007; 20: 21-25.\n[https://doi.org/10.1097/01720610-200710000-00017](https://doi.org/10.1097/01720610-200710000-00017)\nKamal SM. Acute hepatitis C: a systematic review. Am J Gastroenterol 2008; 103: 1283-1297; quiz 1298.\n[https://doi.org/10.1111/j.1572-0241.2008.01825.x](https://doi.org/10.1111/j.1572-0241.2008.01825.x)\nChevaliez S, Pawlotsky JM. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 2007; 13: 2461-2466.\n[https://doi.org/10.3748/wjg.v13.i17.2461](https://doi.org/10.3748/wjg.v13.i17.2461)\nMoradpour D, Penin F, Rice CM. Replication of hepa- titis C virus. Nat Rev Microbiol 2007; 5: 453-463.\n[https://doi.org/10.1038/nrmicro1645](https://doi.org/10.1038/nrmicro1645)\nFranciscus A. A brief history of hepatitis C. Hcspfacts- heet.\n[http://www.hcvadvocate.org](http://www.hcvadvocate.org). Accesado en octu- bre 3 de 2011.\nFeinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975; 292: 767-770.\n[https://doi.org/10.1056/NEJM197504102921502](https://doi.org/10.1056/NEJM197504102921502)\nFerreon JC, Ferreon AC, Li K, Lemon SM. Molecu- lar determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. J Biol Chem 2005; 280: 20483-20492.\n[https://doi.org/10.1074/jbc.M500422200](https://doi.org/10.1074/jbc.M500422200)\nChen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3: 47-52.\n[https://doi.org/10.7150/ijms.3.47](https://doi.org/10.7150/ijms.3.47)\nSimmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962-973.\n[https://doi.org/10.1002/hep.20819](https://doi.org/10.1002/hep.20819)\nAgnello V, Abel G, Elfahal M, Knight GB, Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 1999; 96: 12766-12771.\n[https://doi.org/10.1073/pnas.96.22.12766](https://doi.org/10.1073/pnas.96.22.12766)\nBassett SE, Thomas DL, Brasky KM, Lanford RE. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inocula- ted chimpanzees. J Virol 1999; 73: 1118-1126.\n[https://doi.org/10.1128/JVI.73.2.1118-1126.1999](https://doi.org/10.1128/JVI.73.2.1118-1126.1999)\nRestrepo JC. Serolog\u00edas en las hepatitis virales. Iatreia 2011; 24: 76-86.\nBlanchard E, Belouzard S, Goueslain L, Wakita T, Dubuisson J, Wychowski C, et al. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Vi- rol 2006; 80: 6964-6972.\n[https://doi.org/10.1128/JVI.00024-06](https://doi.org/10.1128/JVI.00024-06)\nLemon SM, Walker CM, Alter MJ, Yi M. Hepatitis C virus. In: Knipe DM, Howley PM (eds). Fields Virology, 5th edition. Philadelphia: Lipincott Williams & Wilkins Pubishers; pp. 1253-1304, 2007.\nPenin F, Dubuisson J, Rey FA, Moradpour D, Pawlots- ky JM. Structural biology of hepatitis C virus. Hepatolo- gy 2004; 39: 5-19.\n[https://doi.org/10.1002/hep.20032](https://doi.org/10.1002/hep.20032)\nShepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5: 558-567.\n[https://doi.org/10.1016/S1473-3099(05)70216-4](https://doi.org/10.1016/S1473-3099(05)70216-4)\nWorld Health Organization. Hepatitis C. Global alert and response.\n[http://www.who.int/csr/disease/hepatitis/](http://www.who.int/csr/disease/hepatitis/) whocdscsrlyo2003/en/index.html. Accesado en agosto 30 de 2011.\nDeuffic-Burban S, Mohamed MK, Larouze B, Carrat F, Valleron AJ. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol 2006; 44: 455-461.\n[https://doi.org/10.1016/j.jhep.2005.08.008](https://doi.org/10.1016/j.jhep.2005.08.008)\nZein NN. Clinical significance of hepatitis C virus geno- types. Clin Microbiol Rev 2000; 13: 223-235.\n[https://doi.org/10.1128/CMR.13.2.223](https://doi.org/10.1128/CMR.13.2.223)\nMendez-Sanchez N, Gutierrez-Grobe Y, Kobashi- Margain RA. Epidemiology of HCV infection in Latin America. Ann Hepatol 2010; 9 Suppl: 27-29.\n[https://doi.org/10.1016/S1665-2681(19)31719-3](https://doi.org/10.1016/S1665-2681(19)31719-3)\nWasley A, Alter MJ. Epidemiology of hepatitis C: geo- graphic differences and temporal trends. Semin Liver Dis 2000; 20: 1-16.\n[https://doi.org/10.1055/s-2000-9506](https://doi.org/10.1055/s-2000-9506)\nAlter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13: 2436-2441.\n[https://doi.org/10.3748/wjg.v13.i17.2436](https://doi.org/10.3748/wjg.v13.i17.2436)\nSpada E, Mele A, Ciccozzi M, Tosti ME, Bianco E, Szklo A, et al. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis sur- veillance system in Italy. Dig Liver Dis 2001; 33: 778- 784.\n[https://doi.org/10.1016/S1590-8658(01)80695-2](https://doi.org/10.1016/S1590-8658(01)80695-2)\nBakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M, El-Kafrawy S, et al. Higher clearance of hepa- titis C virus infection in females compared with males. Gut 2006; 55: 1183-1187.\n[https://doi.org/10.1136/gut.2005.078147](https://doi.org/10.1136/gut.2005.078147)\nSoza A, Riquelme A, Arrese M. Routes of transmission of hepatitis C virus. Ann Hepatol 2010; 9 Suppl: 33.\n[https://doi.org/10.1016/S1665-2681(19)31720-X](https://doi.org/10.1016/S1665-2681(19)31720-X)\nPaintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis 2010; 202: 984-990.\n[https://doi.org/10.1086/656212](https://doi.org/10.1086/656212)\nHauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004; 15: 7-16.\n[https://doi.org/10.1258/095646204322637182](https://doi.org/10.1258/095646204322637182)\nWilkins T, Malcolm JK, Raina D, Schade RR. Hepatitis C: diagnosis and treatment. Am Fam Physician 2010; 81: 1351-1357.\nWilliams I. Epidemiology of hepatitis C in the United States. Am J Med 1999; 107: 2S-9S.\n[https://doi.org/10.1016/S0002-9343(99)00373-3](https://doi.org/10.1016/S0002-9343(99)00373-3)\nDwyre DM, Fernando LP, Holland PV. Hepatitis B, he- patitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang 2011; 100: 92-98.\n[https://doi.org/10.1111/j.1423-0410.2010.01426.x](https://doi.org/10.1111/j.1423-0410.2010.01426.x)\nHladik W, Kataaha P, Mermin J, Purdy M, Otekat G, Lackritz E, et al. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Trop Med Int Health 2006; 11: 951-954.\n[https://doi.org/10.1111/j.1365-3156.2006.01643.x](https://doi.org/10.1111/j.1365-3156.2006.01643.x)\nHahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 2001; 34: 180-187.\n[https://doi.org/10.1053/jhep.2001.25759](https://doi.org/10.1053/jhep.2001.25759)\nHutchinson SJ, Taylor A, Goldberg DJ, Gruer L. Fac- tors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and pre- vention of blood-borne viruses. Addiction 2000; 95: 931-940.\n[https://doi.org/10.1046/j.1360-0443.2000.9569319.x](https://doi.org/10.1046/j.1360-0443.2000.9569319.x)\nAceijas C, Friedman SR, Cooper HL, Wiessing L, Stimson GV, Hickman M. Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution. Sex Transm Infect 2006; 82 Suppl 3: iii10-17.\n[https://doi.org/10.1136/sti.2005.019471](https://doi.org/10.1136/sti.2005.019471)\nContreras AM, Sotelo M, Celis A, Villalobos DB, Ancona-Piste O, Ochoa-Jimenez RJ, et al. [In Process Citation]. Salud Publica Mex 2011; 53 Suppl 1: S19- 25.\nYazdanpanah Y, De Carli G, Migueres B, Lot F, Cam- pins M, Colombo C, et al. Risk factors for hepatitis C virus transmission to health care workers after occu- pational exposure: a European case-control study. Clin Infect Dis 2005; 41: 1423-1430.\n[https://doi.org/10.1086/497131](https://doi.org/10.1086/497131)\nModi AA, Liang TJ. Hepatitis C: a clinical review. Oral Dis 2008; 14: 10-14.\n[https://doi.org/10.1111/j.1601-0825.2007.01419.x](https://doi.org/10.1111/j.1601-0825.2007.01419.x)\nThomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis 2005; 9: 383-398, vi.\n[https://doi.org/10.1016/j.cld.2005.05.003](https://doi.org/10.1016/j.cld.2005.05.003)\nHeller T, Seeff LB. Viral load as a predictor of pro- gression of chronic hepatitis C? Hepatology 2005; 42: 1261-1263.\n[https://doi.org/10.1002/hep.20982](https://doi.org/10.1002/hep.20982)\nIrving WL. Acute hepatitis C virus infection: a neglec- ted disease? Gut 2006; 55: 1075-1077.\n[https://doi.org/10.1136/gut.2005.085407](https://doi.org/10.1136/gut.2005.085407)\nLatin American Association for the Study of the Li- ver Practice Guidelines. Diagnosis, management, and treatment of hepatitis C. Ann Hepatol 2010; 9 Suppl: 8-26.\n[https://doi.org/10.1016/S1665-2681(19)31717-X](https://doi.org/10.1016/S1665-2681(19)31717-X)\nSeeff LB. The history of the \"natural history\" of hepati- tis C (1968-2009). Liver Int 2009; 29 Suppl 1: 89-99.\n[https://doi.org/10.1111/j.1478-3231.2008.01927.x](https://doi.org/10.1111/j.1478-3231.2008.01927.x)\nFattovich G, Stroffolini T, Zagni I, Donato F. Hepa- tocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127: S35-50.\n[https://doi.org/10.1053/j.gastro.2004.09.014](https://doi.org/10.1053/j.gastro.2004.09.014)\nRestrepo JC. Hepatitis virales. In: V\u00e9lez H, Rojas W, Borrero J, Restrepo J, editors. Fundamentos de Medi- cina. Enfermedades infecciosas. Editorial Corporaci\u00f3n para Investigaciones Biol\u00f3gicas CIB. Sexta edici\u00f3n; 2003. p. 169-174.\nAlberti A, Vario A, Ferrari A, Pistis R. Review article: chronic hepatitis C--natural history and cofactors. Ali- ment Pharmacol Ther 2005; 22 Suppl 2: 74-78.\n[https://doi.org/10.1111/j.1365-2036.2005.02602.x](https://doi.org/10.1111/j.1365-2036.2005.02602.x)\nGeorge E, Nadkarni GN, Estrella MM, Lucas GM, Sperati CJ, Atta MG, et al. The Impact of Hepatitis C Coinfection on Kidney Disease Related to Human Im- munodeficiency Virus (HIV): A Biopsy Study. Medicine (Baltimore) 2011; 90: 289-295.\n[https://doi.org/10.1097/MD.0b013e31822f5915](https://doi.org/10.1097/MD.0b013e31822f5915)\nSterling RK, Sulkowski MS. Hepatitis C virus in the set- ting of HIV or hepatitis B virus coinfection. Semin Liver Dis 2004; 24 Suppl 2: 61-68.\n[https://doi.org/10.1055/s-2004-832930](https://doi.org/10.1055/s-2004-832930)\nChu CM, Yeh CT, Liaw YF. Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut 1999; 45: 613-617.\n[https://doi.org/10.1136/gut.45.4.613](https://doi.org/10.1136/gut.45.4.613)\nHepatitis Foundation International.\n[http://www.hepfi.org](http://www.hepfi.org). Accesado el 10 de octubre de 2011.\nOrland JR, Wright TL, Cooper S. Acute hepatitis C. Hepatology 2001; 33: 321-327.\n[https://doi.org/10.1053/jhep.2001.22112](https://doi.org/10.1053/jhep.2001.22112)\nThomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of he- patitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284: 450-456.\n[https://doi.org/10.1001/jama.284.4.450](https://doi.org/10.1001/jama.284.4.450)\nCarvajal JJ, Correa G, Restrepo JC. Hepatitis C aguda. Revisi\u00f3n de un caso. Acta Med Colomb 2008; 33: 28- 32.\nMerican I, Sherlock S, McIntyre N, Dusheiko GM. Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Q J Med 1993; 86: 119-125.\nFoster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quali- ty of life in the absence of cirrhosis. Hepatology 1998; 27: 209-212.\n[https://doi.org/10.1002/hep.510270132](https://doi.org/10.1002/hep.510270132)\nRodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on qua- lity of life. Hepatology 1999; 30: 1299-1301.\n[https://doi.org/10.1002/hep.510300504](https://doi.org/10.1002/hep.510300504)\nSpiegel BM, Younossi ZM, Hays RD, Revicki D, Rob- bins S, Kanwal F. Impact of hepatitis C on health rela- ted quality of life: a systematic review and quantitative assessment. Hepatology 2005; 41: 790-800.\n[https://doi.org/10.1002/hep.20659](https://doi.org/10.1002/hep.20659)\nTong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-1466.\n[https://doi.org/10.1056/NEJM199506013322202](https://doi.org/10.1056/NEJM199506013322202)\nBruno S, Crosignani A, Maisonneuve P, Rossi S, Silini E, Mondelli MU. Hepatitis C virus genotype 1b as a ma- jor risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology 2007; 46: 1350-1356.\n[https://doi.org/10.1002/hep.21826](https://doi.org/10.1002/hep.21826)\nFattovich G, Giustina G, Degos F, Tremolada F, Dio- dati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow- up study of 384 patients. Gastroenterology 1997; 112: 463-472.\n[https://doi.org/10.1053/gast.1997.v112.pm9024300](https://doi.org/10.1053/gast.1997.v112.pm9024300)\nHu KQ, Tong MJ. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology 1999; 29: 1311-1316.\n[https://doi.org/10.1002/hep.510290424](https://doi.org/10.1002/hep.510290424)\nFerri C, Sebastiani M, Giuggioli D, Cazzato M, Lon- gombardo G, Antonelli A, et al. Mixed cryoglobuline- mia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004; 33: 355-374.\n[https://doi.org/10.1016/j.semarthrit.2003.10.001](https://doi.org/10.1016/j.semarthrit.2003.10.001)\nLiang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pa- thogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000; 132: 296-305.\n[https://doi.org/10.7326/0003-4819-132-4-200002150-00008](https://doi.org/10.7326/0003-4819-132-4-200002150-00008)\nGarcia Ferrera WO, Nodarse Cuni H, Moredo Romo E. [Extrahepatic manifestations of infection with hepa- titis C virus]. Rev Gastroenterol Peru 2009; 29: 254- 261.\nGadano A, Galdame O, Marciano S. Diagnosis of pa- tients with suspected chronic hepatitis C infection. Ann Hepatol 2010; 9 Suppl: 34-38.\n[https://doi.org/10.1016/S1665-2681(19)31721-1](https://doi.org/10.1016/S1665-2681(19)31721-1)\nO'Leary JG, Davis GL. Hepatitis C. In: Feldman M, Friedman LS, Brandt LJ (eds). Feldman: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 9th ed. Philadelphia: Saunders, an imprint of Elsevier; pp. 1313-1331, 2010.\nAsociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado, Asociaci\u00f3n Espa\u00f1ola de Gastroenterolog\u00eda, Asocia- ci\u00f3n Latinoamericana para el Estudio del H\u00edgado, Asociaci\u00f3n Interamericana de Gastroenterolog\u00eda. Consenso para el tratamiento de las hepatitis B y C. Gastroenterol Hepatol 2006; 29: 1-241.\nGhany MG, Strader DB, Thomas DL, Seeff LB. Diag- nosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374.\n[https://doi.org/10.1002/hep.22759](https://doi.org/10.1002/hep.22759)\nMoradpour D, Cerny A, Heim MH, Blum HE. Hepa- titis C: an update. Swiss Med Wkly 2001; 131: 291- 298.\nMaheshwari A, Thuluvath PJ. Management of acute hepatitis C. Clin Liver Dis 2010; 14: 169-176; x.\n[https://doi.org/10.1016/j.cld.2009.11.007](https://doi.org/10.1016/j.cld.2009.11.007)\nLauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.\n[https://doi.org/10.1056/NEJM200107053450107](https://doi.org/10.1056/NEJM200107053450107)\nIdrovo V. Asociaci\u00f3n Colombiana de Hepatolog\u00eda. http:// www.higadocolombia.org/index.php?option=com_co ntent&view=article&id=45:aproximacionterapeutica- a-la-hepatitis-por-virus-c. Accesado en octubre 14 de 2011.\nIshiguro S, Inoue M, Tanaka Y, Mizokami M, Iwasaki M, Tsugane S. Impact of viral load of hepatitis C on the incidence of hepatocellular carcinoma: A population- based cohort study (JPHC Study). Cancer Lett 2011; 300: 173-179.\n[https://doi.org/10.1016/j.canlet.2010.10.002](https://doi.org/10.1016/j.canlet.2010.10.002)\nMichaels AJ, Nelson DR. New therapies in the mana- gement of hepatitis C virus. Curr Opin Gastroenterol 2010; 26: 196-201.\n[https://doi.org/10.1097/MOG.0b013e3283383c8f](https://doi.org/10.1097/MOG.0b013e3283383c8f)\nSoriano V, Peters MG, Zeuzem S. New therapies for hepatitis C virus infection. Clin Infect Dis 2009; 48: 313-320.\n[https://doi.org/10.1086/595848](https://doi.org/10.1086/595848)\nMurray KF, Shah U, Mohan N, Heller S, Gonzalez- Peralta RP, Kelly D, et al. Chronic hepatitis. J Pediatr Gastroenterol Nutr 2008; 47: 225-233.\n[https://doi.org/10.1097/MPG.0b013e318181b08b](https://doi.org/10.1097/MPG.0b013e318181b08b)\nCasta\u00f1eda R, Mu\u00f1oz LE. Hepatitis v\u00edricas agudas. In: Mu\u00f1oz LE, ed. Hepatolog\u00eda, 1a ed. M\u00e9xico, DF: Mc- Graw Hill; pp. 75-89, 2007.\nDe la Vega A, Frauca E. Conducta ante la hepatitis por el VHC. In: Jara P, Coordinadora. Protocolos diagn\u00f3sti- cos y terap\u00e9uticos en Pediatr\u00eda, tomo 5: Gastroentero- log\u00eda, Hepatolog\u00eda, Nutrici\u00f3n. Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda; 2002: 203-211.\nLoomba R, Rivera MM, McBurney R, Park Y, Haynes- Williams V, Rehermann B, et al. The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes. Aliment Pharmacol Ther 2011; 33: 559-565.\n[https://doi.org/10.1111/j.1365-2036.2010.04549.x](https://doi.org/10.1111/j.1365-2036.2010.04549.x)\nWright M, Grieve R, Roberts J, Main J, Thomas HC. Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. Health Technol Assess 2006; 10: 1-113, iii.\n[https://doi.org/10.3310/hta10210](https://doi.org/10.3310/hta10210)\nGrieve R, Roberts J, Wright M, Sweeting M, DeAn- gelis D, Rosenberg W, et al. Cost effectiveness of in- terferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C. Gut 2006; 55: 1332-1338.\n[https://doi.org/10.1136/gut.2005.064774](https://doi.org/10.1136/gut.2005.064774)\nSroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Muhlberger N, Wright D, et al. Long-term effecti- veness and cost-effectiveness of antiviral treatment in hepatitis C. J Viral Hepat 2010; 17: 34-50.\n[https://doi.org/10.1111/j.1365-2893.2009.01147.x](https://doi.org/10.1111/j.1365-2893.2009.01147.x)\nFlisiak R, Parfieniuk A. Investigational drugs for hepa- titis C. Expert Opin Investig Drugs 2010; 19: 63-75.\n[https://doi.org/10.1517/13543780903431034](https://doi.org/10.1517/13543780903431034)", "language": null, "image": null, "pagetype": null, "links": ["#pkp_content_main", "#siteNav", "#pkp_content_footer", "\t\t\t\t\t\thttps://medicinaylaboratorio.com/index.php/myl/index\n\t\t\t\t\t", null, "https://medicinaylaboratorio.com/index.php/myl/issue/current", "https://medicinaylaboratorio.com/index.php/myl/issue/archive", "https://medicinaylaboratorio.com/index.php/myl/educontinua", "https://medicinaylaboratorio.com/index.php/myl/about", "https://medicinaylaboratorio.com/index.php/myl/about", "https://medicinaylaboratorio.com/index.php/myl/politica", "https://medicinaylaboratorio.com/index.php/myl/about/editorialTeam", "https://medicinaylaboratorio.com/index.php/myl/contacto", "https://medicinaylaboratorio.com/index.php/myl/search/search", "#", "https://medicinaylaboratorio.com/index.php", "https://doi.org/10.36384/issn.0123-2576", "https://medicinaylaboratorio.com/index.php/myl/user/register", "https://medicinaylaboratorio.com/index.php/myl/login", "https://medicinaylaboratorio.com/index.php", null, "https://medicinaylaboratorio.com/index.php/myl/index", "https://medicinaylaboratorio.com/index.php/myl/issue/archive", "https://medicinaylaboratorio.com/index.php/myl/issue/view/48", "#resumen", "#author", ".downloads_chart", "#references", "#citations", "https://doi.org/10.1097/01720610-200710000-00017", "https://doi.org/10.1111/j.1572-0241.2008.01825.x", "https://doi.org/10.3748/wjg.v13.i17.2461", "https://doi.org/10.1038/nrmicro1645", "http://www.hcvadvocate.org", "https://doi.org/10.1056/NEJM197504102921502", "https://doi.org/10.1074/jbc.M500422200", "https://doi.org/10.7150/ijms.3.47", "https://doi.org/10.1002/hep.20819", "https://doi.org/10.1073/pnas.96.22.12766", "https://doi.org/10.1128/JVI.73.2.1118-1126.1999", "https://doi.org/10.1128/JVI.00024-06", "https://doi.org/10.1002/hep.20032", "https://doi.org/10.1016/S1473-3099(05)70216-4", "http://www.who.int/csr/disease/hepatitis/", "https://doi.org/10.1016/j.jhep.2005.08.008", "https://doi.org/10.1128/CMR.13.2.223", "https://doi.org/10.1016/S1665-2681(19)31719-3", "https://doi.org/10.1055/s-2000-9506", "https://doi.org/10.3748/wjg.v13.i17.2436", "https://doi.org/10.1016/S1590-8658(01)80695-2", "https://doi.org/10.1136/gut.2005.078147", "https://doi.org/10.1016/S1665-2681(19)31720-X", "https://doi.org/10.1086/656212", "https://doi.org/10.1258/095646204322637182", "https://doi.org/10.1016/S0002-9343(99)00373-3", "https://doi.org/10.1111/j.1423-0410.2010.01426.x", "https://doi.org/10.1111/j.1365-3156.2006.01643.x", "https://doi.org/10.1053/jhep.2001.25759", "https://doi.org/10.1046/j.1360-0443.2000.9569319.x", "https://doi.org/10.1136/sti.2005.019471", "https://doi.org/10.1086/497131", "https://doi.org/10.1111/j.1601-0825.2007.01419.x", "https://doi.org/10.1016/j.cld.2005.05.003", "https://doi.org/10.1002/hep.20982", "https://doi.org/10.1136/gut.2005.085407", "https://doi.org/10.1016/S1665-2681(19)31717-X", "https://doi.org/10.1111/j.1478-3231.2008.01927.x", "https://doi.org/10.1053/j.gastro.2004.09.014", "https://doi.org/10.1111/j.1365-2036.2005.02602.x", "https://doi.org/10.1097/MD.0b013e31822f5915", "https://doi.org/10.1055/s-2004-832930", "https://doi.org/10.1136/gut.45.4.613", "http://www.hepfi.org", "https://doi.org/10.1053/jhep.2001.22112", "https://doi.org/10.1001/jama.284.4.450", "https://doi.org/10.1002/hep.510270132", "https://doi.org/10.1002/hep.510300504", "https://doi.org/10.1002/hep.20659", "https://doi.org/10.1056/NEJM199506013322202", "https://doi.org/10.1002/hep.21826", "https://doi.org/10.1053/gast.1997.v112.pm9024300", "https://doi.org/10.1002/hep.510290424", "https://doi.org/10.1016/j.semarthrit.2003.10.001", "https://doi.org/10.7326/0003-4819-132-4-200002150-00008", "https://doi.org/10.1016/S1665-2681(19)31721-1", "https://doi.org/10.1002/hep.22759", "https://doi.org/10.1016/j.cld.2009.11.007", "https://doi.org/10.1056/NEJM200107053450107", "https://doi.org/10.1016/j.canlet.2010.10.002", "https://doi.org/10.1097/MOG.0b013e3283383c8f", "https://doi.org/10.1086/595848", "https://doi.org/10.1097/MPG.0b013e318181b08b", "https://doi.org/10.1111/j.1365-2036.2010.04549.x", "https://doi.org/10.3310/hta10210", "https://doi.org/10.1136/gut.2005.064774", "https://doi.org/10.1111/j.1365-2893.2009.01147.x", "https://doi.org/10.1517/13543780903431034", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/acm-sig-proceedings?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/acs-nano?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/apa?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/associacao-brasileira-de-normas-tecnicas?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/chicago-author-date?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/harvard-cite-them-right?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/ieee?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/modern-language-association?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/turabian-fullnote-bibliography?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/vancouver?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/download/ris?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/download/bibtex?submissionId=368&publicationId=270", "https://medicinaylaboratorio.com/index.php/myl/%20issue/view/48", "https://medicinaylaboratorio.com/index.php/myl/article/view/368/344", "https://medicinaylaboratorio.com/index.php/myl/%20issue/view/48", null, null, null, null, null, null, "https://medicinaylaboratorio.com/index.php/myl/article/view/360", "https://medicinaylaboratorio.com/index.php/myl/issue/view/46", "https://medicinaylaboratorio.com/index.php/myl/article/view/417", "https://medicinaylaboratorio.com/index.php/myl/issue/view/57", "https://medicinaylaboratorio.com/index.php/myl/article/view/481", "https://medicinaylaboratorio.com/index.php/myl/issue/view/67", "https://medicinaylaboratorio.com/index.php/myl/article/view/374", "https://medicinaylaboratorio.com/index.php/myl/issue/view/49", "https://medicinaylaboratorio.com/index.php/myl/article/view/467", "https://medicinaylaboratorio.com/index.php/myl/issue/view/64", "https://medicinaylaboratorio.com/index.php/myl/article/view/383", "https://medicinaylaboratorio.com/index.php/myl/issue/view/51", "https://medicinaylaboratorio.com/index.php/myl/article/view/392", "https://medicinaylaboratorio.com/index.php/myl/issue/view/53", "https://medicinaylaboratorio.com/index.php/myl/article/view/404", "https://medicinaylaboratorio.com/index.php/myl/issue/view/55", "https://medicinaylaboratorio.com/index.php/myl/article/view/493", "https://medicinaylaboratorio.com/index.php/myl/issue/view/70", "https://medicinaylaboratorio.com/index.php/myl/article/view/657", "https://medicinaylaboratorio.com/index.php/myl/issue/view/90", "https://medicinaylaboratorio.com/index.php/myl/user/setLocale/en_US?source=%2Findex.php%2Fmyl%2Farticle%2Fview%2F368", "https://medicinaylaboratorio.com/index.php/myl/user/setLocale/es_ES?source=%2Findex.php%2Fmyl%2Farticle%2Fview%2F368", "https://medicinaylaboratorio.com/index.php/myl/about/submissions", "https://medicinaylaboratorio.com/index.php/myl/proceso", "https://medicinaylaboratorio.com/index.php/myl/contacto", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/18", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/3", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/28", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/20", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/21", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/22", "https://dialnet.unirioja.es/servlet/revista?codigo=27870", "https://www.latindex.org/latindex/ficha/10217", "https://periodica.dgb.unam.mx/F/XQ5EENY222FT41V5ASLD2QI511TJTC1HN4FBXBQHKF9VDT5F6D-11530?func=find-b&request=Medicina+%26+Laboratorio&find_code=WRE&adjacent=N&local_base=PER01&x=57&y=15&filter_code_1=WLN&filter_request_1=&filter_code_2=WYR&filter_request_2=&filter_code_3=WYR&filter_request_3=", "https://lilacs.bvsalud.org/es/revistas-lilacs/revistas-indexadas-en-lilacs/", "https://www.redib.org/Record/oai_revista6619-medicina-y-laboratorio", "https://www.medigraphic.com/cgi-bin/new/publicaciones.cgi?IDREVISTA=215", "https://biblat.unam.mx/es/buscar/revista/medicina&laboratorio", "https://doaj.org/toc/2500-7106?source=%7B%22query%22%3A%7B%22bool%22%3A%7B%22must%22%3A%5B%7B%22terms%22%3A%7B%22index.issn.exact%22%3A%5B%220123-2576%22%2C%222500-7106%22%5D%7D%7D%5D%7D%7D%2C%22size%22%3A100%2C%22sort%22%3A%5B%7B%22created_date%22%3A%7B%22order%22%3A%22desc%22%7D%7D%5D%2C%22_source%22%3A%7B%7D%2C%22track_total_hits%22%3Atrue%7D", "https://scholar.google.com/citations?hl=es&user=vB9lGYIAAAAJ", "/index.php/myl/estadisticas", "/index.php/myl/estadisticas", null, "https://doi.org/10.36384/issn.0123-2576", "https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es", "https://medicinaylaboratoriocom.biteca.online", "https://www.edimeco.com", "https://medicinaylaboratorio.com/index.php/myl/about/aboutThisPublishingSystem"]}